Reuters logo
BRIEF-NODEN PHARMA ANNOUNCES U.S. FDA APPROVAL OF TEKTURNA ORAL PELLETS
November 15, 2017 / 3:57 PM / a month ago

BRIEF-NODEN PHARMA ANNOUNCES U.S. FDA APPROVAL OF TEKTURNA ORAL PELLETS

Nov 15 (Reuters) - Noden Pharma DAC:

* NODEN PHARMA ANNOUNCES FDA APPROVAL OF TEKTURNA®(ALISKIREN) ORAL PELLETS FOR THE TREATMENT OF HYPERTENSION IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER

* NODEN PHARMA DAC SAYS PLANS TO MAKE TEKTURNA ORAL PELLETS AVAILABLE IN 2018​

* ‍NODEN PHARMA DAC SAYS NEW FORMULATION AND PEDIATRIC INDICATION WERE APPROVED THROUGH FDA PRIORITY REVIEW PROCESS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below